Apr 30, 2024 | Alternative Reimbursement Strategies, Biosimilars, Brian Fargus, Brooke Hupp, Caroline Fraker, Fair market reimbursement, Kurt Harden, MedBen Rx, MedBen University, Mental health parity, Municipalities, Nutrigenomics, Pharmacogenomics, Roundtables
At the 18th Annual MedBen University Municipality & Public Employer Roundtable on April 24, clients were shown how MedBen’s self-funding solutions are lowering medical and pharmacy spend while promoting healthier workplaces. Attendees were also introduced to...
Apr 29, 2024 | Access solutions, Alternative Reimbursement Strategies, Benefits preservation, Cost Savings, Direct-to-Employer Contracting, MedBen Rx, Savings, Spousal limitations
It’s hardly shocking that in a new national benefits employer survey, 29 percent of respondents cited “reducing costs” as the most important consideration for employee benefit decisions. However, the steps some employers are using to lower their...
Apr 26, 2024 | Caroline Fraker, Compliance, MedBen University, Mental Health, Mental health parity, Regulatory, Roundtables
At the Municipality & Public Employer Roundtable on April 24, MedBen Senior Vice President Caroline Fraker discussed mental health parity and how proposed rules are expected to affect self-funded employers in 2025. “Mental health and substance use disorder...
Apr 25, 2024 | Chronic conditions, MedBen Access, MedBen WellLiving, Mobile App, Online Services, Preventive Care, Wellness, Wellness compliance, Wellness exam, Wellness screenings
Through early detection and prevention of chronic conditions, MedBen WellLiving clients spend, on average, 6.3% less than non-WellLiving clients. But a proactive strategy is most effective when members are encouraged to schedule recommended wellness exams and...
Apr 16, 2024 | Biosimilars, Cost Savings, Drug costs, Humira, MedBen Rx, Pharmacy, Prescription, Rx Costs, Savings
Last year, MedBen Rx announced a new program that would enable clients to purchase Idacio, a biosimilar version of the anti-inflammatory therapy Humira – a drug that typically costs between $6,000 and $12,000 per month depending on the dose – for under $1,000 per...
